Deranged Biochemical Markers As Early Predictors for the Development of Hepatorenal Syndrome in Patients With Alcoholic Liver Cirrhosis. [PDF]
Deorukhkar D+3 more
europepmc +1 more source
Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: PRO. [PDF]
Belcher JM.
europepmc +1 more source
Outcomes among patients with hepatorenal syndrome based on hospital teaching and transplant status: Analysis of 159 845 hospitalizations. [PDF]
Sohal A+3 more
europepmc +1 more source
Extended criteria donors in liver transplant candidates with hepatorenal syndrome [PDF]
Javier Briceño+5 more
openalex +1 more source
Readmission Rate, Predictors, Outcomes, and Burden of Readmission of Hepatorenal Syndrome in the United States: A Nationwide Analysis. [PDF]
Sohail A+4 more
europepmc +1 more source
Following the MAP for Improved Kidney Function in Hepatorenal Syndrome. [PDF]
Thau MR, Bhatraju PK.
europepmc +1 more source
Use of MARS in Hepatorenal Syndrome — A Local Perspective
Alexander S. Chiu, Sheung Tat Fan
openalex +1 more source
Outcomes of living donor liver transplantation for patients with preoperative type 1 hepatorenal syndrome and acute hepatic decompensation [PDF]
Ksh Chok+7 more
openalex +1 more source
Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: CON. [PDF]
Willows J, Hiremath S.
europepmc +1 more source